ctrl K

AI Score

Unlock

Phathom Pharmaceuticals I... (PHAT)

AI Score

Unlock

5.58

0.37 (7.10%)

At close: Mar 04, 2025, 3:59 PM

5.63

0.81%

After-hours: Mar 04, 2025, 05:49 PM EST

Phathom Pharmaceuticals Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	682K	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	167K	620K	521K	300K	8K	n/a
Gross Profit	515K	-620K	-521K	-300K	-8K	n/a
Operating Income	-167.31M	-172.44M	-135.08M	-125.67M	-106.22M	-1.23M
Interest Income	7.88M	2.13M	41K	1.09M	1.09M	n/a
Pretax Income	-201.59M	-197.72M	-143.88M	-129.07M	-255.13M	-1.29M
Net Income	-201.59M	-223.01M	-148.09M	-133.32M	-209.74M	-1.29M
Selling & General & Admin	117.93M	101M	62.74M	27.52M	6.94M	1.21M
Research & Development	49.9M	71.44M	72.34M	98.15M	99.27M	20K
Other Expenses	n/a	-110K	-2.06M	-8K	-49.56M	-50K
Operating Expenses	167.83M	172.44M	135.08M	125.67M	106.22M	1.23M
Interest Expense	41.97M	27.3M	6.79M	4.58M	4.18M	13K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	167.99M	172.44M	135.08M	125.67M	106.22M	1.23M
Income Tax	n/a	25.28M	4.21M	4.25M	-45.39M	13K
Shares Outstanding (Basic)	51.29M	39.12M	37M	33.23M	24.73M	8.58M
Shares Outstanding (Diluted)	51.29M	39.12M	37M	33.23M	24.73M	8.58M
EPS (Basic)	-3.93	-5.7	-4	-4.01	-8.48	-0.15
EPS (Diluted)	-3.93	-5.7	-4	-4.01	-8.48	-0.15
EBITDA	-159.05M	-171.82M	-134.56M	-124.19M	-250.95M	-50K
Depreciation & Amortization	575K	620K	521K	300K	8K	1.23M